From Algorithm to Answers
AI’s Role in Diagnosing MOGAD
For many MOGAD patients, the road to diagnosis is long, painful, and filled with uncertainty. However, with artificial intelligence on the horizon, that might just change.
Researchers at Emory University are among those leading this difference. Their team is actively using AI to analyze patient samples to detect biomarkers that can possibly, in the future, make it so that diagnosing MOGAD is easier and less difficult, even making it possible to predict relapses in patients.
One of the most promising areas involves MRI imaging. Scientists are investigating whether a pattern called leptomeningeal enhancement (LME), which is detectable on a standard MRI, and could serve as a biomarker for MOGAD, potentially identifying the disease within days, while antibody test results labs can take some time for them to return.
In the end, artificial intelligence is rapidly transforming medical diagnostics, pushing the drive for more efficient clinical decision-making, with the systems being pointed towards diseases like MOGAD, helping families and patients through their journey.